Treatment of allergic asthma with loratadine and salmeterol versus montelukast

Dumitrascu, D.; Simon, B.; Varga, M.; Arion, D.

+ Site Statistics

References:

53,623,987

Abstracts:

29,492,080

+ Search Articles

+ Subscribe to Site Feeds

Treatment of allergic asthma with loratadine and salmeterol versus montelukast

Treatment of allergic asthma with loratadine and salmeterol versus montelukast

Dumitrascu, D.; Simon, B.; Varga, M.; Arion, D.

Allergy (Copenhagen) 56(Supplement 68): 99

2001

(PDF 0-2 workdays service: $29.90)

Accession: 035980905

Download citation: RIS BibTeX Text

Related references

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. Journal of Allergy and Clinical Immunology 104(3 Pt 1): 547-553, 1999

Effects of montelukast , loratadine, montelukast + loratadine and placebo in seasonal allergic rhinitis and conjunctivitis. Journal of Allergy & Clinical Immunology 101(1 PART 2): S97, 1998

A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma. Journal of Asthma 46(5): 465-469, 2009

Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy and Asthma Proceedings 33(2): E17-E22, 2012

Cost-effectiveness analysis of fluticasone propionate/salmeterol combination versus montelukast in the treatment of adults with asthma. Journal of Allergy & Clinical Immunology 109(1 Supplement): S185, January, 2002

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma. Pharmacoeconomics 20(13): 909-918, 2002

Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy and Asthma Proceedings 31(1): 68-75, 2010

Concomitant montelukast and loratadine provide rapid significant improvement in seasonal allergic rhinitis compared with loratadine alone. European Respiratory Journal 12(SUPPL 28): 274S, Sept, 1998

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Journal of Allergy & Clinical Immunology 104(3 PART 1): 547-553, Sept, 1999

Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children. Asian Pacific Journal of Allergy and Immunology 26(2-3): 89-95, 2008

Prophylactic treatment with loratadine versus cromolyn sodium in children with mild-to-moderate perennial allergic asthma. Current Therapeutic Research 59(8): 567-578, 1998

In patients taking fluticasone propionate/salmeterol 100/50mug Dislus for asthma, fluticasone propionate nasal spray 200mug QD is superior to montelukast 10mg QD in the treatment of allergic rhinitis in patients with coexistent allergic rhinitis Implication for the one airway hypothesis. Journal of Allergy & Clinical Immunology 113(2 Supplement): S200, February, 2004

A comparison of fexofenadine/pseudoephedrine and loratadine/montelukast in the treatment of seasonal allergic rhinitis. Journal of Allergy & Clinical Immunology 111(2 Abstract Supplement): S73, February, 2003

Superior asthma control with the FP/salmeterol combination product BID versus oral montelukast QD as first-line therapy. Journal of Allergy & Clinical Immunology 107(2): S98, February, 2001

Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. Journal of Asthma 47(1): 76-82, 2010

< Previous

∧ Chapter

Next >